Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Antituberculosis agent-1

Antituberculosis agent-1 (Compound 8a) is an antituberculosis agent with an MIC of 3.84 μg/mL against M. tuberculosis H37Rv[1].

Product Specifications

CAS Number

2411740-98-0

UNSPSC

12352005

Target

Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/antituberculosis-agent-1.html

Solubility

10 mM in DMSO

Smiles

O=C1C=C(C2=CC=C(O)C=C2)OC3=CC=C(O)C(CN4CCCCC4)=C13

Molecular Formula

C21H21NO4

Molecular Weight

351.40

References & Citations

[1]Zhao W, et al. Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis. Eur J Med Chem. 2020 Mar 1;189:112075.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

More Discoveries

Explore Other Products

Browse additional items from our catalog

Canine Copeptin, CPP ELISA KIT
E0419Ca-01 48 Well

Canine Copeptin, CPP ELISA KIT

Sign In for Pricing
View Details
Canine Copeptin, CPP ELISA KIT
E0419Ca-02 96 Well

Canine Copeptin, CPP ELISA KIT

Sign In for Pricing
View Details
Canine Copeptin, CPP ELISA KIT
E0419Ca-03 5x 96 Tests

Canine Copeptin, CPP ELISA KIT

Sign In for Pricing
View Details
Canine Copeptin, CPP ELISA KIT
E0419Ca-04 10x 96 Tests

Canine Copeptin, CPP ELISA KIT

Sign In for Pricing
View Details
Clec3a sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
K6686206 1.0 µg DNA

Clec3a sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)

Sign In for Pricing
View Details
Lentiviral human CTNNBIP1 shRNA (UAS) - Lentiviral human CTNNBIP1 shRNA (UAS, iRFP) (25)
GTR15334589 1 Vial

Lentiviral human CTNNBIP1 shRNA (UAS) - Lentiviral human CTNNBIP1 shRNA (UAS, iRFP) (25)

Sign In for Pricing
View Details